Forkhead box proteins: tuning forks for transcriptional harmony.
The DOI matches its Crossref record; 198 of the 199 references it cites were found in a registry or an index.
Abstract
Forkhead box (FOX) proteins are multifaceted transcription factors that are responsible for fine-tuning the spatial and temporal expression of a broad range of genes both during development and in adult tissues. This function is engrained in their ability to integrate a multitude of cellular and environmental signals and to act with remarkable fidelity. Several key members of the FOXA, FOXC, FOXM, FOXO and FOXP subfamilies are strongly implicated in cancer, driving initiation, maintenance, progression and drug resistance. The functional complexities of FOX proteins are coming to light and have established these transcription factors as possible therapeutic targets and putative biomarkers for specific cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been suggested that crosstalk between RB and mitogenic AKT signaling pathways play a key role in the quiescence to senescence switch by regulating overlapping functions of Forkhead transcription factors, FOXO3a and FOXM1 (Eijkelenboom and Burgering, 2013; Lam et al., 2013; Imai et al., 2014).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Lam et al., 2013
Citations
Cites
2 retracted
Wang, Z., Banerjee, S., Kong, D., Li, Y., & Sarkar, F. H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1265 · Cited by 245
RetractedBao, B., Wang, Z., Ali, S., Kong, D., Banerjee, S., Ahmad, A., Li, Y., Azmi, A. S., Miele, L., & Sarkar, F. H. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23150 · Cited by 206
RetractedComprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Differential oestrogen receptor binding is associated with clinical outcome in breast cancer
Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R., Dunning, M. J., Brown, G. D., Gojis, O., Ellis, I. O., Green, A. R., et al. (2012) · Nature · doi:10.1038/nature10730 · Cited by 2,173
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
Pioneer transcription factors: establishing competence for gene expression
Zaret, K. S., & Carroll, J. S. (2011) · Genes & Development · doi:10.1101/gad.176826.111 · Cited by 1,589
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
Barbieri, C. E., Baca, S. C., Lawrence, M. S., Demichelis, F., Blattner, M., Theurillat, J.-P., White, T. A., Stojanov, P., Van Allen, E., Stransky, N., et al. (2012) · Nature Genetics · doi:10.1038/ng.2279 · Cited by 1,558
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
Medema, R. H., Kops, G. J. P. L., Bos, J. L., & Burgering, B. M. T. (2000) · Nature · doi:10.1038/35008115 · Cited by 1,438
Differential Oestrogen Receptor Binding is Associated with Clinical Outcome in Breast Cancer
Stark, R. (2012) · Lecture Notes in Computer Science · doi:10.1007/978-3-642-29627-7_30 · Cited by 1,403
Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.008 · Cited by 1,384
Opening of Compacted Chromatin by Early Developmental Transcription Factors HNF3 (FoxA) and GATA-4
Cirillo, L. A., Lin, F. R., Cuesta, I., Friedman, D., Jarnik, M., & Zaret, K. S. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00459-8 · Cited by 1,185
Calnan, D. R., & Brunet, A. (2008) · Oncogene · doi:10.1038/onc.2008.21 · Cited by 1,170
Unified nomenclature for the winged helix/forkhead transcription factors
Kaestner, K. H., Knöchel, W., & Martínez, D. E. (2000) · Genes & Development · doi:10.1101/gad.14.2.142 · Cited by 1,158
The emerging roles of forkhead box (Fox) proteins in cancer
Myatt, S. S., & Lam, E. W. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2223 · Cited by 1,070
Self-citationEpithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
Sarrió, D., Rodriguez-Pinilla, S. M., Hardisson, D., Cano, A., Moreno-Bueno, G., & Palacios, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2017 · Cited by 1,056
Taube, J. H., Herschkowitz, J. I., Komurov, K., Zhou, A. Y., Gupta, S., Yang, J., Hartwell, K., Onder, T. T., Gupta, P. B., Evans, K. W., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004900107 · Cited by 1,041
FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis
Paik, J.-H., Kollipara, R., Chu, G., Ji, H., Xiao, Y., Ding, Z., Miao, L., Tothova, Z., Horner, J. W., Carrasco, D. R., et al. (2007) · Cell · doi:10.1016/j.cell.2006.12.029 · Cited by 1,032
Seoane, J., Le, H.-V., Shen, L., Anderson, S. A., & Massagué, J. (2004) · Cell · doi:10.1016/s0092-8674(04)00298-3 · Cited by 1,028
FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription
Lupien, M., Eeckhoute, J., Meyer, C. A., Wang, Q., Zhang, Y., Li, W., Carroll, J. S., Liu, X. S., & Brown, M. (2008) · Cell · doi:10.1016/j.cell.2008.01.018 · Cited by 983
Deacetylase inhibition promotes the generation and function of regulatory T cells
Tao, R., de Zoeten, E. F., Özkaynak, E., Chen, C., Wang, L., Porrett, P. M., Li, B., Turka, L. A., Olson, E. N., Greene, M. I., et al. (2007) · Nature Medicine · doi:10.1038/nm1652 · Cited by 924
IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3a
Hu, M. C.-T., Lee, D.-F., Xia, W., Golfman, L. S., Ou-Yang, F., Yang, J.-Y., Zou, Y., Bao, S., Hanada, N., Saso, H., et al. (2004) · Cell · doi:10.1016/s0092-8674(04)00302-2 · Cited by 868
CREB-binding Protein and p300 in Transcriptional Regulation
Vo, N., & Goodman, R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r000025200 · Cited by 866
Brunet, A., Park, J., Tran, H., Hu, L. S., Hemmings, B. A., & Greenberg, M. E. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.952-965.2001 · Cited by 860
DNA Repair Pathway Stimulated by the Forkhead Transcription Factor FOXO3a Through the Gadd45 Protein
Tran, H., Brunet, A., Grenier, J. M., Datta, S. R., Fornace, A. J., DiStefano, P. S., Chiang, L. W., & Greenberg, M. E. (2002) · Science · doi:10.1126/science.1068712 · Cited by 860
A Conserved MST-FOXO Signaling Pathway Mediates Oxidative-Stress Responses and Extends Life Span
Lehtinen, M. K., Yuan, Z., Boag, P. R., Yang, Y., Villén, J., Becker, E. B. E., DiBacco, S., de la Iglesia, N., Gygi, S., Blackwell, T. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.03.046 · Cited by 839
Greer, E. L., Oskoui, P. R., Banko, M. R., Maniar, J. M., Gygi, M. P., Gygi, S. P., & Brunet, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705325200 · Cited by 818
FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK
Essers, M. A., Weijzen, S., de Vries‐Smits, A. M., Saarloos, I., de Ruiter, N. D., Bos, J. L., & Burgering, B. M. T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600476 · Cited by 798
Weigel, D., Jürgens, G., Küttner, F., Seifert, E., & Jäckle, H. (1989) · Cell · doi:10.1016/0092-8674(89)90133-5 · Cited by 782
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Yang, J.-Y., Zong, C. S., Xia, W., Yamaguchi, H., Ding, Q., Xie, X., Lang, J.-Y., Lai, C.-C., Chang, C.-J., Huang, W.-C., et al. (2008) · Nature Cell Biology · doi:10.1038/ncb1676 · Cited by 697
Dijkers, P. F., Medema, R. H., Pals, C., Banerji, L., Thomas, N. S. B., Lam, E. W.-F., Burgering, B. M. T., Raaijmakers, J. A. M., Lammers, J.-W. J., Koenderman, L., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9138-9148.2000 · Cited by 617
Self-citationZhang, N., Wei, P., Gong, A., Chiu, W.-T., Lee, H.-T., Colman, H., Huang, H., Xue, J., Liu, M., Wang, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.08.016 · Cited by 584
The initiation of liver development is dependent on Foxa transcription factors
Lee, C. S., Friedman, J. R., Fulmer, J. T., & Kaestner, K. H. (2005) · Nature · doi:10.1038/nature03649 · Cited by 581
Anders, L., Ke, N., Hydbring, P., Choi, Y. J., Widlund, H. R., Chick, J. M., Zhai, H., Vidal, M., Gygi, S. P., Braun, P., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.001 · Cited by 543
Mihaylova, M. M., Vasquez, D. S., Ravnskjaer, K., Denechaud, P.-D., Yu, R. T., Alvarez, J. G., Downes, M., Evans, R. M., Montminy, M., & Shaw, R. J. (2011) · Cell · doi:10.1016/j.cell.2011.03.043 · Cited by 533
Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization
Potente, M., Urbich, C., Sasaki, K.-I., Hofmann, W. K., Heeschen, C., Aicher, A., Kollipara, R., DePinho, R. A., Zeiher, A. M., & Dimmeler, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23126 · Cited by 531
Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation
Huang, H., Regan, K. M., Wang, F., Wang, D., Smith, D. I., van Deursen, J. M. A., & Tindall, D. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406789102 · Cited by 518
Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
Bidwell, B. N., Slaney, C. Y., Withana, N. P., Forster, S., Cao, Y., Loi, S., Andrews, D., Mikeska, T., Mangan, N. E., Samarajiwa, S. A., et al. (2012) · Nature Medicine · doi:10.1038/nm.2830 · Cited by 487
Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells
Ouyang, W., Beckett, O., Ma, Q., Paik, J.-H., DePinho, R. A., & Li, M. O. (2010) · Nature Immunology · doi:10.1038/ni.1884 · Cited by 467
Arginine Methylation of FOXO Transcription Factors Inhibits Their Phosphorylation by Akt
Yamagata, K., Daitoku, H., Takahashi, Y., Namiki, K., Hisatake, K., Kako, K., Mukai, H., Kasuya, Y., & Fukamizu, A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.09.013 · Cited by 435
SIRT Inhibitors Induce Cell Death and p53 Acetylation through Targeting Both SIRT1 and SIRT2
Peck, B., Chen, C.-Y., Ho, K.-K., Di Fruscia, P., Myatt, S. S., Coombes, R. C., Fuchter, M. J., Hsiao, C.-D., & Lam, E. W.-F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0971 · Cited by 433
Self-citationKong, D., Banerjee, S., Ahmad, A., Li, Y., Wang, Z., Sethi, S., & Sarkar, F. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012445 · Cited by 411
Li, B., Samanta, A., Song, X., Iacono, K. T., Bembas, K., Tao, R., Basu, S., Riley, J. L., Hancock, W. W., Shen, Y., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700298104 · Cited by 410
FOXM1: From cancer initiation to progression and treatment
Koo, C.-Y., Muir, K. W., & Lam, E. W.-F. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.09.004 · Cited by 406
Self-citationZuo, T., Wang, L., Morrison, C., Chang, X., Zhang, H., Li, W., Liu, Y., Wang, Y., Liu, X., Chan, M. W. Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.034 · Cited by 395
Foxa1 and Foxa2 Are Essential for Sexual Dimorphism in Liver Cancer
Li, Z., Tuteja, G., Schug, J., & Kaestner, K. H. (2012) · Cell · doi:10.1016/j.cell.2011.11.026 · Cited by 382
FOXO Proteins Regulate Tumor Necrosis Factor-related Apoptosis Inducing Ligand Expression
Modur, V., Nagarajan, R., Evers, B. M., & Milbrandt, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207509200 · Cited by 371
Kalinichenko, V. V., Major, M. L., Wang, X., Petrovic, V., Kuechle, J., Yoder, H. M., Dennewitz, M. B., Shin, B., Datta, A., Raychaudhuri, P., et al. (2004) · Genes & Development · doi:10.1101/gad.1200704 · Cited by 356
Fu, Z., Malureanu, L., Huang, J., Wang, W., Li, H., van Deursen, J. M., Tindall, D. J., & Chen, J. (2008) · Nature Cell Biology · doi:10.1038/ncb1767 · Cited by 355
FoxO6, a Novel Member of the FoxO Class of Transcription Factors with Distinct Shuttling Dynamics
Jacobs, F. M. J., van der Heide, L. P., Wijchers, P. J. E. C., Burbach, J. P. H., Hoekman, M. F. M., & Smidt, M. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302804200 · Cited by 341
Kim, I.-M., Ackerson, T., Ramakrishna, S., Tretiakova, M., Wang, I.-C., Kalin, T. V., Major, M. L., Gusarova, G. A., Yoder, H. M., Costa, R. H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3003 · Cited by 337
CDK2-Dependent Phosphorylation of FOXO1 as an Apoptotic Response to DNA Damage
Huang, H., Regan, K. M., Lou, Z., Chen, J., & Tindall, D. J. (2006) · Science · doi:10.1126/science.1130512 · Cited by 336
Foxp1 is an essential transcriptional regulator of B cell development
Hu, H., Wang, B., Borde, M., Nardone, J., Maika, S., Allred, L., Tucker, P. W., & Rao, A. (2006) · Nature Immunology · doi:10.1038/ni1358 · Cited by 328
Myatt, S. S., Wang, J., Monteiro, L. J., Christian, M., Ho, K.-K., Fusi, L., Dina, R. E., Brosens, J. J., Ghaem-Maghami, S., & Lam, E. W.-F. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1891 · Cited by 318
Self-citationThe MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression
Sadasivam, S., Duan, S., & DeCaprio, J. A. (2012) · Genes & Development · doi:10.1101/gad.181933.111 · Cited by 309
Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
Robinson, J. L. L., MacArthur, S., Ross‐Innes, C. S., Tilley, W. D., Neal, D. E., Mills, I. G., & Carroll, J. S. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.216 · Cited by 300
Foxp2 and Foxp1 cooperatively regulate lung and esophagus development
Shu, W., Lu, M. M., Zhang, Y., Tucker, P. W., Zhou, D., & Morrisey, E. E. (2007) · Development · doi:10.1242/dev.02846 · Cited by 296
Essafi, A., Fernández de Mattos, S., Hassen, Y. A. M., Soeiro, I., Mufti, G. J., Thomas, N. S. B., Medema, R. H., & Lam, E. W.-F. (2005) · Oncogene · doi:10.1038/sj.onc.1208421 · Cited by 293
Self-citationWhat are regulatory T cells (Treg) regulating in cancer and why?
Whiteside, T. L. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.03.004 · Cited by 291
Spiteri, E., Konopka, G., Coppola, G., Bomar, J., Oldham, M., Ou, J., Vernes, S. C., Fisher, S. E., Ren, B., & Geschwind, D. H. (2007) · The American Journal of Human Genetics · doi:10.1086/522237 · Cited by 285
Takata, R., Akamatsu, S., Kubo, M., Takahashi, A., Hosono, N., Kawaguchi, T., Tsunoda, T., Inazawa, J., Kamatani, N., Ogawa, O., et al. (2010) · Nature Genetics · doi:10.1038/ng.635 · Cited by 283
Gao, N., Zhang, J., Rao, M. A., Case, T. C., Mirosevich, J., Wang, Y., Jin, R., Gupta, A., Rennie, P. S., & Matusik, R. J. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0020 · Cited by 279
Bakker, W. J., Harris, I. S., & Mak, T. W. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.10.035 · Cited by 277
FOXC2 Expression Links Epithelial–Mesenchymal Transition and Stem Cell Properties in Breast Cancer
Hollier, B. G., Tinnirello, A. A., Werden, S. J., Evans, K. W., Taube, J. H., Sarkar, T. R., Sphyris, N., Shariati, M., Kumar, S. V., Battula, V. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2962 · Cited by 277
Kalin, T. V., Wang, I.-C., Ackerson, T. J., Major, M. L., Detrisac, C. J., Kalinichenko, V. V., Lyubimov, A., & Costa, R. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3138 · Cited by 274
The transcription factor FOXM1 is a cellular target of the natural product thiostrepton
Hegde, N. S., Sanders, D. A., Rodriguez, R., & Balasubramanian, S. (2011) · Nature Chemistry · doi:10.1038/nchem.1114 · Cited by 269
Vernes, S. C., Spiteri, E., Nicod, J., Groszer, M., Taylor, J. M., Davies, K. E., Geschwind, D. H., & Fisher, S. E. (2007) · The American Journal of Human Genetics · doi:10.1086/522238 · Cited by 268
Major, M. L., Lepe, R., & Costa, R. H. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2649-2661.2004 · Cited by 266
Cooperative interaction between retinoic acid receptor-α and estrogen receptor in breast cancer
Ross-Innes, C. S., Stark, R., Holmes, K. A., Schmidt, D., Spyrou, C., Russell, R., Massie, C. E., Vowler, S. L., Eldridge, M., & Carroll, J. S. (2010) · Genes & Development · doi:10.1101/gad.552910 · Cited by 260
Update of human and mouse forkhead box (FOX) gene families
Jackson, B. C., Carpenter, C., Nebert, D. W., & Vasiliou, V. (2010) · Human Genomics · doi:10.1186/1479-7364-4-5-345 · Cited by 260
Kwok, J. M.-M., Myatt, S. S., Marson, C. M., Coombes, R. C., Constantinidou, D., & Lam, E. W.-F. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0188 · Cited by 252
Self-citationFOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2
Zuo, T., Liu, R., Zhang, H., Chang, X., Liu, Y., Wang, L., Zheng, P., & Liu, Y. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32538 · Cited by 249
FOXA1 is an essential determinant of ERα expression and mammary ductal morphogenesis
Bernardo, G. M., Lozada, K. L., Miedler, J. D., Harburg, G., Hewitt, S. C., Mosley, J. D., Godwin, A. K., Korach, K. S., Visvader, J. E., Kaestner, K. H., et al. (2010) · Development · doi:10.1242/dev.043299 · Cited by 247
Tan, Y., Raychaudhuri, P., & Costa, R. H. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01068-06 · Cited by 246
Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c
Ma, R. Y. M., Tong, T. H. K., Cheung, A. M. S., Tsang, A. C. C., Leung, W. Y., & Yao, K.-M. (2005) · Journal of Cell Science · doi:10.1242/jcs.01657 · Cited by 231
FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer
Ray, P. S., Wang, J., Qu, Y., Sim, M.-S., Shamonki, J., Bagaria, S. P., Ye, X., Liu, B., Elashoff, D., Hoon, D. S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4120 · Cited by 231
Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation
Wang, F., Chan, C.-H., Chen, K., Guan, X., Lin, H.-K., & Tong, Q. (2012) · Oncogene · doi:10.1038/onc.2011.347 · Cited by 230
Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers
Sérandour, A. A., Avner, S., Percevault, F., Demay, F., Bizot, M., Lucchetti-Miganeh, C., Barloy-Hubler, F., Brown, M., Lupien, M., Métivier, R., et al. (2011) · Genome Research · doi:10.1101/gr.111534.110 · Cited by 226
Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate
Wang, L., Liu, R., Li, W., Chen, C., Katoh, H., Chen, G.-Y., McNally, B., Lin, L., Zhou, P., Zuo, T., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.016 · Cited by 218
PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types
Britten, C. D. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2121-1 · Cited by 216
FOXM1 Confers Acquired Cisplatin Resistance in Breast Cancer Cells
Kwok, J. M.-M., Peck, B., Monteiro, L. J., Schwenen, H. D. C., Millour, J., Coombes, R. C., Myatt, S. S., & Lam, E. W.-F. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0432 · Cited by 207
Self-citationFoxa2 and H2A.Z Mediate Nucleosome Depletion during Embryonic Stem Cell Differentiation
Li, Z., Gadue, P., Chen, K., Jiao, Y., Tuteja, G., Schug, J., Li, W., & Kaestner, K. H. (2012) · Cell · doi:10.1016/j.cell.2012.11.018 · Cited by 202
Kong, S. L., Li, G., Loh, S. L., Sung, W., & Liu, E. T. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.59 · Cited by 202
Xia, L., Huang, W., Tian, D., Zhu, H., Qi, X., Chen, Z., Zhang, Y., Hu, H., Fan, D., Nie, Y., et al. (2013) · Hepatology · doi:10.1002/hep.26029 · Cited by 198
Activation of FOXO1 by Cdk1 in Cycling Cells and Postmitotic Neurons
Yuan, Z., Becker, E. B. E., Merlo, P., Yamada, T., DiBacco, S., Konishi, Y., Schaefer, E. M., & Bonni, A. (2008) · Science · doi:10.1126/science.1152337 · Cited by 190
Bochkis, I. M., Rubins, N. E., White, P., Furth, E. E., Friedman, J. R., & Kaestner, K. H. (2008) · Nature Medicine · doi:10.1038/nm.1853 · Cited by 186
ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and Resistance
Millour, J., de Olano, N., Horimoto, Y., Monteiro, L. J., Langer, J. K., Aligue, R., Hajji, N., & Lam, E. W.-F. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0024 · Cited by 184
Self-citationHui, R. C.-Y., Francis, R. E., Guest, S. K., Costa, J. R., Gomes, A. R., Myatt, S. S., Brosens, J. J., & Lam, E. W.-F. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0397 · Cited by 184
Self-citationRegulation of FoxO activity by CBP/p300-mediated acetylation
van der Heide, L. P., & Smidt, M. P. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.12.002 · Cited by 183
Robbins, C. M., Tembe, W. A., Baker, A., Sinari, S., Moses, T. Y., Beckstrom-Sternberg, S., Beckstrom-Sternberg, J., Barrett, M., Long, J., Chinnaiyan, A., et al. (2011) · Genome Research · doi:10.1101/gr.107961.110 · Cited by 180
Rousso, D. L., Pearson, C. A., Gaber, Z. B., Miquelajauregui, A., Li, S., Portera-Cailliau, C., Morrisey, E. E., & Novitch, B. G. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.024 · Cited by 180
FoxM1 Mediates Resistance to Herceptin and Paclitaxel
Carr, J. R., Park, H. J., Wang, Z., Kiefer, M. M., & Raychaudhuri, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0545 · Cited by 180
Foxa2 integrates the transcriptional response of the hepatocyte to fasting
Zhang, L., Rubins, N. E., Ahima, R. S., Greenbaum, L. E., & Kaestner, K. H. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.07.002 · Cited by 177
Madureira, P. A., Varshochi, R., Constantinidou, D., Francis, R. E., Coombes, R. C., Yao, K.-M., & Lam, E. W.-F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603906200 · Cited by 177
Self-citationChung, T. K. H., Lau, T. S., Cheung, T. H., Yim, S. F., Lo, K. W. K., Siu, N. S. S., Chan, L. K. Y., Yu, M. Y., Kwong, J., Doran, G., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26060 · Cited by 176
Karadedou, C. T., Gomes, A., Chen, J., Petkovic, M., Ho, K. K. K., Zwolińska, A., Feltes, A., Wong, S. Y. S., Chan, K. Y. K., Cheung, Y., et al. (2011) · Oncogene · doi:10.1038/onc.2011.368 · Cited by 175
Self-citationSeo, S., & Kume, T. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2006.06.012 · Cited by 168
A Novel FoxM1-Caveolin Signaling Pathway Promotes Pancreatic Cancer Invasion and Metastasis
Huang, C., Qiu, Z., Wang, L., Peng, Z., Jia, Z., Logsdon, C. D., Le, X., Wei, D., Huang, S., & Xie, K. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3102 · Cited by 168
SIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer
Khongkow, M., Olmos, Y., Gong, C., Gomes, A. R., Monteiro, L. J., Yagüe, E., Cavaco, T. B., Khongkow, P., Man, E. P. S., Laohasinnarong, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt098 · Cited by 168
Self-citationA cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment
Gusarova, G. A., Wang, I., Major, M. L., Kalinichenko, V. V., Ackerson, T. J., Petrovic, V., & Costa, R. H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27527 · Cited by 167
FOXO3a Promotes Tumor Cell Invasion through the Induction of Matrix Metalloproteinases
Störz, P., Döppler, H. R., Copland, J. A., Simpson, K. J., & Toker, A. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00077-09 · Cited by 167
Pro-proliferative FoxM1 is a target of p53-mediated repression
Barsotti, A. M., & Prives, C. (2009) · Oncogene · doi:10.1038/onc.2009.282 · Cited by 166
Bettini, M. L., Pan, F., Bettini, M., Finkelstein, D., Rehg, J. E., Floess, S., Bell, B. D., Ziegler, S. F., Huehn, J., Pardoll, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.020 · Cited by 166
AP‐2γ regulates oestrogen receptor‐mediated long‐range chromatin interaction and gene transcription
Tan, S. K., Lin, Z. H., Chang, C. W., Varang, V., Chng, K. R., Pan, Y. F., Yong, E., Sung, W.-K. K., & Cheung, E. C. W. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.151 · Cited by 165
Laoukili, J., Alvarez, M., Meijer, L. A. T., Stahl, M., Mohammed, S., Kleij, L., Heck, A. J. R., & Medema, R. H. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01710-07 · Cited by 163
The Transcription Factor Encyclopedia
Yusuf, D., Butland, S. L., Swanson, M. I., Bolotin, E., Ticoll, A., Cheung, W., Zhang, X. Y. C., Dickman, C. T., Fulton, D. L., Lim, J. S., et al. (2012) · Genome biology · doi:10.1186/gb-2012-13-3-r24 · Cited by 162
Self-citationInduction of Mxi1-SR α by FOXO3a Contributes to Repression of Myc-Dependent Gene Expression
Delpuech, O., Griffiths, B., East, P., Essafi, A., Lam, E. W.-F., Burgering, B., Downward, J., & Schulze, A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01789-06 · Cited by 161
Self-citationFoxO3a and BCR-ABL Regulate cyclin D2 Transcription through a STAT5/BCL6-Dependent Mechanism
Fernández de Mattos, S., Essafi, A., Soeiro, I., Pietersen, A. M., Birkenkamp, K. U., Edwards, C. S., Martino, A., Nelson, B. H., Francis, J. M., Jones, M. C., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.10058-10071.2004 · Cited by 161
Self-citationMillour, J., Constantinidou, D., Stavropoulou, A. V., Wilson, M., Myatt, S. S., Kwok, J. M.-M., Sivanandan, K., Coombes, R. C., Medema, R. H., Hartman, J., et al. (2010) · Oncogene · doi:10.1038/onc.2010.47 · Cited by 161
Self-citationYoshida, Y., Wang, I., Yoder, H. M., Davidson, N. O., & Costa, R. H. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.01.036 · Cited by 160
Kwon, H.-S., Lim, H. W., Wu, J., Schnölzer, M., Verdin, E., & Ott, M. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1100903 · Cited by 159
Hui, R. C.-Y., Gomes, A., Constantinidou, D., Costa, J. R., Karadedou, C. T., de Mattos, S. F., Wymann, M. P., Brosens, J. J., Schulze, A., & Lam, E. W. ‐. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01265-07 · Cited by 154
Self-citationHo, K.-K., McGuire, V. A., Koo, C.-Y., Muir, K., de Olano, N., Maifoshie, E., Kelly, D. J., McGovern, U., Monteiro, L. J., Gomes, A., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.284224 · Cited by 152
Self-citationFoxM1 Regulates Transcription of JNK1 to Promote the G1/S Transition and Tumor Cell Invasiveness
Wang, I., Chen, Y., Hughes, D. E., Ackerson, T. J., Major, M. L., Kalinichenko, V. V., Costa, R. H., Raychaudhuri, P., Tyner, A. L., & Lau, L. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709892200 · Cited by 150
A FOXO3–IRF7 gene regulatory circuit limits inflammatory sequelae of antiviral responses
Litvak, V., Ratushny, A. V., Lampano, A., Schmitz, F., Huang, A. C., Raman, A. T., Rust, A. G., Bergthaler, A., Aitchison, J. D., & Aderem, A. A. (2012) · Nature · doi:10.1038/nature11428 · Cited by 150
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer
Lam (2009) · International Journal of Oncology · doi:10.3892/ijo_00000313 · Cited by 141
Dong, X.-Y., Chen, C., Sun, X., Guo, P., Vessella, R. L., Wang, R.-X., Chung, L. W. K., Zhou, W., & Dong, J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0411 · Cited by 140
Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer
McGovern, U., Francis, R. E., Peck, B., Guest, S. K., Wang, J., Myatt, S. S., Krol, J., Kwok, J. M.-M., Polychronis, A., Coombes, R. C., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0805 · Cited by 138
Self-citationSanders, D. A., Ross-Innes, C. S., Beraldi, D., Carroll, J. S., & Balasubramanian, S. (2013) · Genome biology · doi:10.1186/gb-2013-14-1-r6 · Cited by 137
Chromatin Opening and Stable Perturbation of Core Histone:DNA Contacts by FoxO1
Hatta, M., & Cirillo, L. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704735200 · Cited by 134
Zhang, H., & Sun, H. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.06.001 · Cited by 130
Lin, L., Miller, C. T., Contreras, J. I., Prescott, M. S., Dagenais, S. L., WU, R. T., Yee, J., Orringer, M. B., Misek, D. E., Hanash, S., et al. (2002) · PubMed · Cited by 128
Wang, F., Marshall, C. B., Yamamoto, K., Li, G., Gasmi-Seabrook, G. M. C., Okada, H., Mak, T. W., & Ikura, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119073109 · Cited by 125
Zhang, N., Wu, X.-J., Yang, L., Xiao, F., Zhang, H., Zhou, A., Huang, Z., & Huang, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0039 · Cited by 125
Liu, R., Wang, L., Chen, G., Katoh, H., Chen, C., Liu, Y., & Zheng, P. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3717 · Cited by 121
Xie, Z., Tan, G., Ding, M., Dong, D., Chen, T., Meng, X., Huang, X., & Tan, Y. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq715 · Cited by 114
Chen, Y.-J., Dominguez‐Brauer, C., Wang, Z., Asara, J. M., Costa, R. H., Tyner, A. L., Lau, L. F., & Raychaudhuri, P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.007997 · Cited by 111
The tumor suppressive role of miRNA-370 by targeting FoxM1 in acute myeloid leukemia
Zhang, X., Zeng, J., Zhou, M., Li, B., Zhang, Y., Huang, T., Wang, L., Jia, J., & Chen, C. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-56 · Cited by 110
Olmos, Y., Brosens, J. J., & Lam, E. W. ‐. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.12.001 · Cited by 107
Self-citationThe Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment
Monteiro, L. J., Khongkow, P., Kongsema, M., Morris, J. R., Man, C., Weekes, D. B., Koo, C.-Y., Gomes, A., Pinto, P. H., Varghese, V., et al. (2012) · Oncogene · doi:10.1038/onc.2012.491 · Cited by 105
Self-citationDeGraff, D. J., Clark, P. E., Cates, J., Yamashita, H., Robinson, V. L., Yu, X., Smolkin, M. E., Chang, S. S., Cookson, M. S., Herrick, M. K., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036669 · Cited by 105
Induction of Human Epithelial Stem/Progenitor Expansion by FOXM1
Gemenetzidis, E., Costea, D. E., Parkinson, E. K., Waseem, A., Wan, H., & Teh, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2173 · Cited by 105
Chen, J., Gomes, A., Monteiro, L. J., Wong, S. Y., Wu, L. H., Ng, T.-T., Karadedou, C. T., Millour, J., Ip, Y.-C., Cheung, Y.-N., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012293 · Cited by 105
Self-citationLi, W., Wang, L., Katoh, H., Liu, R., Zheng, P., & Liu, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3268 · Cited by 105
FOXC1 regulates the functions of human basal-like breast cancer cells by activating NF-κB signaling
Wang, J., Ray, P., Sim, M.-S., Zhou, X. Z., Lu, K. P., Lee, A. V., Lin, X., Bagaria, S. P., Giuliano, A. E., & Cui, X. (2012) · Oncogene · doi:10.1038/onc.2011.635 · Cited by 104
Genomic Determinants of PI3K Pathway Inhibitor Response in Cancer
Weigelt, B., & Downward, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00109 · Cited by 102
FoxM1 in Tumorigenicity of the Neuroblastoma Cells and Renewal of the Neural Progenitors
Wang, Z., Park, H. J., Carr, J. R., Chen, Y., Zheng, Y., Li, J., Tyner, A. L., Costa, R. H., Bagchi, S., & Raychaudhuri, P. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4087 · Cited by 102
Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma
Yasui, H., Hideshima, T., Richardson, P. G. G., & Anderson, K. C. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05860.x · Cited by 101
Cooperative regulation in development by SMRT and FOXP1Preprint
Jepsen, K., Gleiberman, A. S., Shi, C., Simon, D. I., & Rosenfeld, M. G. (2008) · Genes & Development · doi:10.1101/gad.1637108 · Cited by 100
Fox, S. B., Brown, P., Han, C., Ashe, S., Leek, R., Harris, A. L., & Banham, A. H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0461 · Cited by 98
Ciechomska, I. A., Pyrzyńska, B., Kaźmierczak, P., & Kaminska, B. (2003) · Oncogene · doi:10.1038/sj.onc.1207137 · Cited by 98
The Foxc2 Transcription Factor Regulates Angiogenesis via Induction of Integrin β3 Expression*
Hayashi, H., Sano, H., Seo, S., & Kume, T. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800190200 · Cited by 97
de Keizer, P. L. J., Packer, L. M., Szypowska, A. A., Riedl-Polderman, P. E., van den Broek, N. J. F., de Bruin, A., Dansen, T. B., Marais, R., Brenkman, A. B., & Burgering, B. M. T. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1563 · Cited by 94
Krol, J., Francis, R. E., Albergaria, A., Sunters, A., Polychronis, A., Coombes, R. C., & Lam, E. W. ‐. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0507 · Cited by 94
Self-citationFoxA1 is a Key Mediator of Hormonal Response in Breast and Prostate Cancer
Robinson, J. L. L., & Carroll, J. S. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00068 · Cited by 94
Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb
Down, C. F., Millour, J., Lam, E. W. ‐., & Watson, R. J. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.03.008 · Cited by 90
Self-citationSizemore, S. T., & Keri, R. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.375865 · Cited by 90
Yan, J., Xu, L., Crawford, G. E., Wang, Z., & Burgess, S. M. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.1.155-168.2006 · Cited by 90
Teh, M., Gemenetzidis, E., Patel, D., Tariq, R., Nadir, A., Bahta, A. W., Waseem, A., & Hutchison, I. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034329 · Cited by 83
FoxM1 Regulates Mammary Luminal Cell Fate
Carr, J. R., Kiefer, M. M., Park, H. J., Li, J., Wang, Z., Fontanarosa, J., DeWaal, D., Kopanja, D., Benevolenskaya, E. V., Guzman, G., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.05.005 · Cited by 82
Garrett, C. R., Coppola, D., Wenham, R. M., Cubitt, C. L., Neuger, A. M., Frost, T. J., Lush, R. M., Sullivan, D. M., Cheng, J. Q., & Sebti, S. M. (2010) · Investigational New Drugs · doi:10.1007/s10637-010-9479-2 · Cited by 79
Priller, M., Pöschl, J., Abrão, L., von Bueren, A. O., Cho, Y., Rutkowski, S., Kretzschmar, H. A., & Schüller, U. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1214 · Cited by 77
FOXO and FOXM1 in Cancer: The FOXO-FOXM1 Axis Shapes the Outcome of Cancer Chemotherapy
Wilson, M., Brosens, J. J., Schwenen, H. D. C., & Lam, E. W. ‐. (2011) · Current Drug Targets · doi:10.2174/138945011796150244 · Cited by 76
Self-citationFOXO transcription factor-dependent p15INK4b and p19INK4d expression
Katayama, K., Nakamura, A., Sugimoto, Y., TSURUO, T., & Fujita, N. (2007) · Oncogene · doi:10.1038/sj.onc.1210813 · Cited by 75
Non-Overlapping Progesterone Receptor Cistromes Contribute to Cell-Specific Transcriptional Outcomes
Clarke, C. L., & Graham, J. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035859 · Cited by 74
FoxP4, a novel forkhead transcription factor
Teufel, A., Wong, E. A., Mukhopadhyay, M., Malik, N., & Westphal, H. (2003) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(03)00074-5 · Cited by 72
Balli, D., Zhang, Y., Snyder, J. E., Kalinichenko, V. V., & Kalin, T. V. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2004 · Cited by 72
Wang, I., Meliton, L. N., Ren, X., Zhang, Y., Balli, D., Snyder, J. E., Whitsett, J. A., Kalinichenko, V. V., & Kalin, T. V. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006609 · Cited by 71
Chokas, A. L., Trivedi, C. M., Lu, M. M., Tucker, P. W., Li, S., Epstein, J. A., & Morrisey, E. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088468 · Cited by 71
Li, H., Ren, Z., Kang, X., Zhang, L., Li, X., Wang, Y., Xue, T., Shen, Y.-F., & Liu, Y. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-366 · Cited by 71
Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4
Wierstra, I., & Alves, J. (2006) · Biological Chemistry · doi:10.1515/bc.2006.119 · Cited by 70
Feng, J., Zhang, X., Zhu, H., Wang, X., Ni, S., & Huang, J. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcpdhqfnyjz01yg · Cited by 70
Fu, G., & Peng, C. (2011) · Oncogene · doi:10.1038/onc.2011.127 · Cited by 69
The Foxc2 transcription factor regulates tumor angiogenesis
Sano, H., LeBoeuf, J. P., Novitskiy, S., Seo, S., Zaja-Milatovic, S., Dikov, M., & Kume, T. (2010) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2010.01.015 · Cited by 69
Wang, I., Snyder, J. E., Zhang, Y., Lander, J. M., Nakafuku, Y., Lin, J. A., Chen, G., Kalin, T. V., Whitsett, J. A., & Kalinichenko, V. V. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00355-12 · Cited by 67
FOXM1: The Achilles' heel of cancer?
Radhakrishnan, S. K., & Gartel, A. L. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2223-c1 · Cited by 66
Howarth, K., Blood, K. A., Ng, B. L., Beavis, J. C., Chua, Y. W., Cooke, S. L., Raby, S., Ichimura, K., Collins, V. P., Carter, N. P., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210993 · Cited by 65
The cooperative roles of Foxc1 and Foxc2 in cardiovascular development.
Kume, T. (2009) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-1599-3_5 · Cited by 63
Shigekawa, T., Ijichi, N., Ikeda, K., Horie‐Inoue, K., Shimizu, C., Saji, S., Aogi, K., Tsuda, H., Osaki, A., Saeki, T., et al. (2011) · Hormones and Cancer · doi:10.1007/s12672-011-0082-6 · Cited by 61
Takayama, K., Horie‐Inoue, K., Ikeda, K., Urano, T., Murakami, K., Hayashizaki, Y., Ouchi, Y., & Inoue, S. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.056 · Cited by 58
Giatromanolaki, A. N., Koukourakis, M. I., Sivridis, E., Gatter, K. C., Harris, A. L., & Banham, A. H. (2005) · Modern Pathology · doi:10.1038/modpathol.3800494 · Cited by 56
Berry, F. B., Mirzayans, F., & Walter, M. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513629200 · Cited by 55
The p38 MAPK–MK2 Axis Regulates E2F1 and FOXM1 Expression after Epirubicin Treatment
de Olano, N., Koo, C.-Y., Monteiro, L. J., Pinto, P. H., Gomes, A., Aligué, R., & Lam, E. W. ‐. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0559 · Cited by 55
Self-citationPrognostic significance of FOXP1 as an oncogene in hepatocellular carcinoma
Zhang, Y., Zhang, S., Wang, X., Liu, J., Yang, L., He, S., Chen, L., & Huang, J. (2012) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2011-200547 · Cited by 52
p120-Catenin Is Transcriptionally Downregulated by FOXC2 in Non–Small Cell Lung Cancer Cells
Mortazavi, F., An, J., Dubinett, S. M., & Rettig, M. B. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0004 · Cited by 52
Myatt, S. S., & Lam, E. W. ‐. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2223-c2 · Cited by 52
Self-citationSynergistic Interplay between Promoter Recognition and CBP/p300 Coactivator Recruitment by FOXO3a
Wang, F., Marshall, C. B., Li, G., Yamamoto, K., Mak, T. W., & Ikura, M. (2009) · ACS Chemical Biology · doi:10.1021/cb900190u · Cited by 47
Smith, G. R., & Shanley, D. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011092 · Cited by 46
Teh, M., Hutchison, I. L., Costea, D. E., Neppelberg, E., Liavaag, P. G., Purdie, K. J., Harwood, C. A., Wan, H., Odell, E. W., Hackshaw, A. K., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27886 · Cited by 46
Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity
Zhang, H., Xiao, Y., Zhu, Z., Li, B., & Greene, M. I. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2011.101 · Cited by 46
Zaret, K. S., Caravaca, J. M., Tulin, A. V., & Sekiya, T. (2010) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2010.75.061 · Cited by 42
Banham, A. H., Boddy, J., Launchbury, R., Han, C., Turley, H., Malone, P. R., Harris, A. L., & Fox, S. B. (2007) · The Prostate · doi:10.1002/pros.20583 · Cited by 41
Lützner, N., Arce, J. D.-C., & Rösl, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032590 · Cited by 39
Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells
Campbell, A. J., Lyne, L., Brown, P. J., Launchbury, R., Bignone, P. A., Chi, J., Roncador, G., Lawrie, C. H., Gatter, K. C., Kušec, R., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08070.x · Cited by 39
Strödicke, M., Karberg, S., & Korge, G. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00371-3 · Cited by 37
Stable Chromatin Binding Prevents FoxA Acetylation, Preserving FoxA Chromatin Remodeling
Kohler, S., & Cirillo, L. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.063149 · Cited by 37
Two Lysines in the Forkhead Domain of Foxp3 Are Key to T Regulatory Cell Function
Liu, Y., Wang, L., Han, R., Beier, U. H., & Hancock, W. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029035 · Cited by 35
Taslim, C., Chen, Z., Huang, K., Huang, T. H. ‐., Wang, Q., & Lin, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks139 · Cited by 31
Toma, M. I., Weber, T., Meinhardt, M., Zastrow, S., Grimm, M., Fuessel, S., Wirth, M. P., & Baretton, G. B. (2011) · Cancer Investigation · doi:10.3109/07357907.2010.535059 · Cited by 29
Danciu, T., Chupreta, S., Cruz, O., Fox, J. E., Whitman, M., & Iñiguez-Lluhı́, J. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.339424 · Cited by 29
Kirkwood, J. M., & Tarhini, A. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1540 · Cited by 25
Santisteban, P., Recacha, P., Metzger, D. E., & Zaret, K. S. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22217 · Cited by 24
Lee, E. J., Kim, J. M., Lee, M. K., & Jameson, J. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002743 · Cited by 15
Regulation of cardiomyocyte proliferation by Foxp1
Wang, Y., & Morrisey, E. E. (2010) · Cell Cycle · doi:10.4161/cc.9.21.13924 · Cited by 10
Complexity Made Simple in Diffuse Large B-Cell Lymphoma
Aster, J. C., & Kutok, J. L. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1444 · Cited by 6
Cited by
Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype
Kumari, R., & Jat, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.645593 · Cited by 1,622
Cyclic Decidualization of the Human Endometrium in Reproductive Health and Failure
Gellersen, B., & Brosens, J. J. (2014) · Endocrine Reviews · doi:10.1210/er.2014-1045 · Cited by 1,139
Self-citationAMPK–SKP2–CARM1 signalling cascade in transcriptional regulation of autophagy
Shin, H.-J. R., Kim, H., Oh, S., Lee, J.-G., Kee, M., Ko, H.-J., Kweon, M.-N., Won, K.-J., & Baek, S. H. (2016) · Nature · doi:10.1038/nature18014 · Cited by 417
FOXO transcription factor family in cancer and metastasis
Jiramongkol, Y., & Lam, E. W.-F. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09883-w · Cited by 281
“FOXOs are considered to be tumour suppressors by virtue of their established functions in cell cycle arrest, senescence, apoptosis, differentiation, DNA damage repair and scavenging of reactive oxygen species [2].”
BackgroundInfluentialSelf-citationPROTACs: great opportunities for academia and industry (an update from 2020 to 2021)
He, M., Cao, C., Ni, Z., Liu, Y., Song, P., Hao, S., He, Y., Sun, X., & Rao, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00999-9 · Cited by 283
Metadata
- Authors
- Lam, E. W.-F., Brosens, J. J., Gomes, A. R., & Koo, C.-Y.
- Affiliations
- Hammersmith Hospital (GB)
- University Hospital Coventry (GB)
- Corresponding author
- Lam, Eric W.-F.
- Venue
- Nature Reviews Cancer
- Published
- 2013-06-24
- Volume
- 13
- Issue
- 7
- Pages
- 482-495
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2076174368
- Cited by
- 684
- References
- 199
- Citations by year
- 2026: 20 · 2025: 45 · 2024: 52 · 2023: 65 · 2022: 67 · 2021: 70 · 2020: 57 · 2019: 64 · 2018: 56 · 2017: 56 · 2016: 51 · 2015: 53 · 2014: 24 · 2013: 2
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancer Research UK (12011)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- forkhead transcription factor, FoxA, FOXO, FoxP, gene expression regulation, cancer, therapeutic target, biomarkers, drug resistance, signal integration
- MeSH terms
- Antineoplastic Agents, Humans, Neoplasms, Forkhead Transcription Factors, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.